Evergreen Capital Management’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
Other funds holding IBB
CB
Evergreen Capital Management's IBB Position: Q2 2026 in Review
Evergreen Capital Management reduced its iShares Biotechnology ETF (IBB) stake by 0.04% in Q2 2026, selling an estimated $1.72K and leaving 27,427 shares worth $5.22M. The position accounts for 0.09% of the portfolio, ranked #200.
Evergreen Capital Management first reported a position in IBB in Q2 2018 and has held it in 20 quarters since. The position peaked at $8.45M in Q1 2023. 956 funds tracked by Wall St. Rank hold IBB as of Q2 2026.
- Evergreen Capital Management held 27,427 shares of iShares Biotechnology ETF worth $5.22M as of Q2 2026.
- Evergreen Capital Management sold 10 iShares Biotechnology ETF shares in Q2 2026, an estimated $1.72K.
- iShares Biotechnology ETF made up 0.09% of Evergreen Capital Management's portfolio in Q2 2026, its #200 holding.
- Evergreen Capital Management first reported a position in iShares Biotechnology ETF in Q2 2018 and has held it in 20 quarters since.
- Evergreen Capital Management's iShares Biotechnology ETF position peaked at $8.45M in Q1 2023.
- 956 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.
Based on Evergreen Capital Management's 13F filing for Q2 2026, filed 23 Jul 2026.